Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

NCT06726096 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

615

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis (RA)
Anti IL-6R

Interventions

BIOLOGICAL: Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection

Sponsor

Beijing VDJBio Co., LTD.